# Packet 01.5 — Discovery Pass 44

STATUS: DISCOVERY IN PROGRESS
PHASE: PROBLEM FINDING ONLY
ROUTING: NOT STARTED
DATE: 2026-06-13

This pass looks for biotechnology, genomics, gene-editing, synthetic-biology, genomic-privacy, biosafety, ecological-release, hereditary, access-inequality, commercialization, and long-term biological-stewardship failure.

## Provisional records

### GENOME-001 — Genetic association is presented as individual destiny

Population-level correlation may be interpreted as certainty about one person’s health, behavior, ancestry, or future.

HARM: probabilistic evidence becomes deterministic identity and treatment.

OVERLAP TO CHECK: HEALTH-001, INFER-001.

### GENOME-002 — Reference genome underrepresents some populations

Variant calling, diagnosis, risk scoring, and ancestry inference may perform worse where reference data is sparse.

HARM: some populations receive more uncertain or incorrect genomic interpretation.

OVERLAP TO CHECK: LANG-002, DESIGN-004.

### GENOME-003 — Variant classification changes after clinical decisions are made

A variant may move between benign, uncertain, and pathogenic as evidence grows.

HARM: earlier treatment, anxiety, reproduction, or family decisions rest on an obsolete interpretation.

OVERLAP TO CHECK: GOVREC-002, MEDINT-003.

### GENOME-004 — Genetic result reveals information about nonconsenting relatives

One person’s test may expose parentage, disease risk, ancestry, or family relationships of others.

HARM: individual consent creates involuntary family disclosure.

OVERLAP TO CHECK: FAMILY-003, PARTICIP-002.

### GENOME-005 — Mosaicism and tissue variation are missed by one sample

Blood, saliva, tumor, embryo, and other tissues may not share the same genetic state.

HARM: a clean or abnormal result is generalized beyond the sampled tissue.

OVERLAP TO CHECK: CONTAM-004, DESIGN-004.

### GENOME-006 — Genomic interpretation depends on undisclosed population assumptions

Risk models may encode ancestry categories, prevalence estimates, environmental history, and family structure.

HARM: interpretation appears objective while relying on hidden demographic assumptions.

OVERLAP TO CHECK: FRAME-003, CULT-003.

### GENEEDIT-001 — Off-target editing remains undetected outside tested regions

Assays may focus on predicted sites and miss structural changes, rare edits, or tissue-specific effects.

HARM: unintended genomic change persists beneath apparently successful validation.

OVERLAP TO CHECK: TEST-004, QUALITY-001.

### GENEEDIT-002 — On-target edit creates an unintended biological effect

The intended sequence change may alter regulation, protein folding, development, immunity, or nearby genes.

HARM: precise editing is mistaken for precise biological outcome.

OVERLAP TO CHECK: INTERACT-001, DESIGN-003.

### GENEEDIT-003 — Edited cells gain a selection advantage not seen in short studies

Small growth, survival, or immune differences may expand over time.

HARM: a rare edited-cell property becomes a delayed dominant harm.

OVERLAP TO CHECK: DESIGN-006, REBOUND-001.

### GENEEDIT-004 — Germline edit affects people who cannot consent

Changes may pass to descendants and interact with future environments and genetic backgrounds.

HARM: irreversible risk is imposed across generations.

OVERLAP TO CHECK: PARTICIP-001, HERED-001.

### GENEEDIT-005 — Editing success is measured by sequence rather than whole-organism outcome

A corrected locus may coexist with developmental, metabolic, behavioral, or reproductive effects.

HARM: molecular success masks organism-level failure.

OVERLAP TO CHECK: MEAS-004, SPACE-003.

### GENEEDIT-006 — Access to corrective editing becomes tied to enhancement markets

Clinical treatment, cosmetic use, performance enhancement, and social status may share infrastructure and incentives.

HARM: therapeutic capability expands into unequal pressure to enhance.

OVERLAP TO CHECK: ADS-003, BIOACCESS-002.

### SYNBIO-001 — Engineered organism behaves differently outside laboratory conditions

Temperature, nutrients, competition, mutation, hosts, and ecological stress may change its function.

HARM: controlled behavior does not survive environmental release.

OVERLAP TO CHECK: REPRO-003, ECOREL-001.

### SYNBIO-002 — Genetic circuit fails gradually rather than visibly

Mutation, burden, drift, contamination, and host adaptation may alter output while the organism remains viable.

HARM: a biological system continues operating after its intended control is lost.

OVERLAP TO CHECK: SAT-004, CALIB-001.

### SYNBIO-003 — Containment depends on one biological assumption

Auxotrophy, temperature sensitivity, kill switches, mating barriers, or dependency may fail under mutation or environmental substitution.

HARM: nominal containment collapses through an alternative biological path.

OVERLAP TO CHECK: MONO-001, INTERACT-001.

### SYNBIO-004 — Standard biological parts are context-dependent

Promoters, enzymes, vectors, chassis, and pathways may interact differently across organisms and conditions.

HARM: modular design language overstates transferability.

OVERLAP TO CHECK: PORT-001, MATERIAL-002.

### SYNBIO-005 — Automated design optimizes measurable function while ignoring biosafety

Yield, stability, growth, or production may improve while persistence, transfer, virulence, or ecological fitness rises.

HARM: optimization increases dangerous biological capability.

OVERLAP TO CHECK: RECOMMEND-001, DUAL-001.

### SYNBIO-006 — DNA synthesis screening misses distributed harmful assembly

Individually permitted sequences, vendors, fragments, and modifications may combine into a hazardous system.

HARM: component-level review misses end-to-end biological capability.

OVERLAP TO CHECK: DUAL-004, INTERACT-001.

### BIOSEC-001 — Pathogen or toxin work is mislabeled as low risk from intended use

Benign purpose may obscure transmissibility, host range, environmental persistence, or misuse potential.

HARM: intent substitutes for capability-based risk assessment.

OVERLAP TO CHECK: DUAL-001, HAZMAT-001.

### BIOSEC-002 — Biosafety cabinet or containment certification does not match actual workflow

Crowding, movement, aerosols, equipment, cleaning, and worker technique may invalidate tested performance.

HARM: certified equipment creates false assurance during real use.

OVERLAP TO CHECK: LAB-002, GUARD-002.

### BIOSEC-003 — Sample identity is lost across collection, culture, sequencing, and storage

Barcode error, plate shift, contamination, relabeling, and software mapping may attach results to the wrong organism or person.

HARM: biological action is taken on misidentified material.

OVERLAP TO CHECK: LAB-001, TRACEPROD-001.

### BIOSEC-004 — Incident reporting is delayed by fear of program shutdown or blame

Exposure, contamination, escape, or procedural deviation may remain informal.

HARM: containment weakness persists and contacts lose timely protection.

OVERLAP TO CHECK: LAB-006, MINEWORK-001.

### BIOSEC-005 — Decontamination removes viable organisms but not all biological hazard

Toxins, spores, nucleic acids, allergens, and resistant material may remain after treatment.

HARM: a successful kill claim is mistaken for complete hazard removal.

OVERLAP TO CHECK: CONTAM-003, HAZMAT-004.

### PRIVGEN-001 — Genomic data cannot be fully anonymized

Sequence uniqueness, genealogy, public databases, and family links may allow reidentification.

HARM: privacy promises exceed the nature of the data.

OVERLAP TO CHECK: MIN-001, DATA-006.

### PRIVGEN-002 — Genomic deletion cannot remove copies held by relatives and derived models

Family databases, backups, research cohorts, embeddings, and risk scores may retain linked information.

HARM: one person’s withdrawal cannot fully reclaim genomic exposure.

OVERLAP TO CHECK: SACRED-003, PRIVRIGHT-002.

### PRIVGEN-003 — Forensic or law-enforcement use expands beyond original consent

Consumer, medical, ancestry, and research data may become searchable for unrelated investigations.

HARM: voluntary testing creates population-scale surveillance.

OVERLAP TO CHECK: POLICE-005, PARTICIP-001.

### PRIVGEN-004 — Insurer, employer, or platform infers genetics without direct access

Family history, behavior, medication, ancestry, and correlated traits may approximate genomic risk.

HARM: legal limits on genetic data are bypassed through inference.

OVERLAP TO CHECK: ADS-002, CREDIT-005.

### PRIVGEN-005 — Genetic parentage discovery creates safety and identity harm

Unexpected relationships, donor conception, adoption, infidelity, or family secrets may be revealed abruptly.

HARM: informational accuracy causes relational, psychological, or physical danger without support.

OVERLAP TO CHECK: FAMILY-003, ABUSE-007.

### ECOREL-001 — Released organism spreads beyond the intended geography

Wind, water, animals, trade, migration, and human transport may move it across boundaries.

HARM: local authorization creates transboundary ecological exposure.

OVERLAP TO CHECK: CONTAM-006, JUR-001.

### ECOREL-002 — Gene drive changes populations faster than governance can respond

Inheritance bias may spread through wild populations before monitoring, consent, or reversal is possible.

HARM: irreversible ecological change outruns institutional control.

OVERLAP TO CHECK: CONFLICT-006, RESTORE-004.

### ECOREL-003 — Ecological monitoring misses low-frequency early spread

Sparse sampling, seasonal gaps, species movement, and detection limits may delay recognition.

HARM: intervention begins after containment is no longer feasible.

OVERLAP TO CHECK: REMSENSE-003, OBS-003.

### ECOREL-004 — Reversal organism creates a second uncontrolled intervention

A rescue drive, competitor, predator, or corrective release may have its own evolutionary and ecological effects.

HARM: remediation compounds uncertainty rather than restoring baseline.

OVERLAP TO CHECK: CONTAM-003, RESTORE-002.

### ECOREL-005 — Ecological benefit accounting ignores non-target species and cultural use

Pest control, conservation, or productivity gains may omit food webs, pollinators, sacred species, and local livelihoods.

HARM: aggregate benefit hides ecological and cultural loss.

OVERLAP TO CHECK: EJ-002, NORM-005.

### HERED-001 — Heritable intervention commits future generations to an irreversible state

Descendants cannot consent and may face different environments, diseases, and social conditions.

HARM: present choices lock future people into unknown biological consequences.

OVERLAP TO CHECK: GENEEDIT-004, STEWARD-001.

### HERED-002 — Hereditary risk information changes how families treat children before symptoms exist

Expectations, surveillance, insurance, education, and reproduction decisions may shift around uncertain risk.

HARM: probability becomes a social identity imposed on the child.

OVERLAP TO CHECK: CHILD-006, GENOME-001.

### HERED-003 — Embryo selection narrows acceptable human variation

Disease avoidance may blend into preference for traits, identity, sex, disability status, or social desirability.

HARM: reproductive choice creates structural pressure against certain kinds of people.

OVERLAP TO CHECK: REPRO-002, REP-002.

### HERED-004 — Long-term effects cannot be separated from family and environment

Biological inheritance, upbringing, exposure, and social treatment may interact across generations.

HARM: causal claims about hereditary interventions remain uncertain while consequences persist.

OVERLAP TO CHECK: DESIGN-002, DEV-004.

### BIOACCESS-001 — Genomic and biotech benefits are concentrated in well-represented populations

Research, diagnostics, trials, and therapies may follow profitable or data-rich groups.

HARM: scientific progress widens existing health inequality.

OVERLAP TO CHECK: GENOME-002, HEALTH-005.

### BIOACCESS-002 — High-cost therapy creates biological class division

Gene therapy, cell therapy, fertility intervention, and personalized treatment may be available only to wealthy users or systems.

HARM: preventable biological disadvantage becomes economically inherited.

OVERLAP TO CHECK: PRICE-001, SPACEACCESS-001.

### BIOACCESS-003 — Patent and platform control blocks independent validation and local production

Sequences, vectors, cell lines, models, manufacturing methods, and data may remain proprietary.

HARM: safety, affordability, and continuity depend on a small number of owners.

OVERLAP TO CHECK: LOCK-001, PUBSCI-005.

### BIOACCESS-004 — Commercial ancestry categories harden contested identities

Population clusters may be marketed as discrete, stable, and socially meaningful groups.

HARM: probabilistic genetic patterns reinforce racial or cultural essentialism.

OVERLAP TO CHECK: CULT-001, GENOME-006.

### BIOACCESS-005 — Long-term biological stewardship lacks durable funding and authority

Biobanks, edited populations, ecological releases, clinical registries, and adverse-effect monitoring may require decades of care.

HARM: biological obligations outlive projects, companies, grants, and regulators.

OVERLAP TO CHECK: STEWARD-001, SUCCESS-001.

## Pass 44 result

New provisional records: 42
Routing decisions made: 0
Records closed: 0
Deduplication required later: Yes
Discovery saturation: NOT REACHED

Combined working total:
- Existing baseline: 122
- Pass 01 provisional: 10
- Pass 02 provisional: 20
- Pass 03 provisional: 21
- Pass 04 provisional: 29
- Pass 05 provisional: 33
- Pass 06 provisional: 35
- Pass 07 provisional: 40
- Pass 08 provisional: 44
- Pass 09 provisional: 42
- Pass 10 provisional: 43
- Pass 11 provisional: 44
- Pass 12 provisional: 43
- Pass 13 provisional: 43
- Pass 14 provisional: 42
- Pass 15 provisional: 42
- Pass 16 provisional: 42
- Pass 17 provisional: 42
- Pass 18 provisional: 42
- Pass 19 provisional: 42
- Pass 20 provisional: 42
- Pass 21 provisional: 42
- Pass 22 provisional: 42
- Pass 23 provisional: 42
- Pass 24 provisional: 42
- Pass 25 provisional: 42
- Pass 26 provisional: 42
- Pass 27 provisional: 42
- Pass 28 provisional: 42
- Pass 29 provisional: 42
- Pass 30 provisional: 42
- Pass 31 provisional: 42
- Pass 32 provisional: 42
- Pass 33 provisional: 42
- Pass 34 provisional: 42
- Pass 35 provisional: 42
- Pass 36 provisional: 42
- Pass 37 provisional: 42
- Pass 38 provisional: 42
- Pass 39 provisional: 42
- Pass 40 provisional: 42
- Pass 41 provisional: 42
- Pass 42 provisional: 42
- Pass 43 provisional: 42
- Pass 44 provisional: 42
- Current preserved plus provisional: 1871

NEXT DISCOVERY PASS:
Oceans, fisheries, coastal systems, marine transport, seabed activity, marine contamination, ecosystem monitoring, coastal communities, and long-term ocean stewardship.

END PACKET 01.5 — DISCOVERY PASS 44
